Microbicide drug candidates to prevent HIV infection
- 14 February 2007
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 369 (9563) , 787-797
- https://doi.org/10.1016/s0140-6736(07)60202-5
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- In Vitro Microbicidal Activity of the Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI) UC781 against NNRTI-Resistant Human Immunodeficiency Virus Type 1Journal of Virology, 2006
- Cellulose Acetate 1,2-Benzenedicarboxylate Inhibits Infection by Cell-Free and Cell-Associated Primary HIV-1 IsolatesAIDS Research and Human Retroviruses, 2006
- Envelope Conformational Changes Induced by Human Immunodeficiency Virus Type 1 Attachment Inhibitors Prevent CD4 Binding and Downstream Entry EventsJournal of Virology, 2006
- Cyclotriazadisulfonamides: promising new CD4-targeted anti-HIV drugsJournal of Antimicrobial Chemotherapy, 2005
- Multiple Vaginal Exposures to Low Doses of R5 Simian‐Human Immunodeficiency Virus: Strategy to Study HIV Preclinical Interventions in Nonhuman PrimatesThe Journal of Infectious Diseases, 2005
- Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophagesEuropean Journal of Immunology, 2003
- Diversity of receptors binding HIV on dendritic cell subsetsNature Immunology, 2002
- Sodium Lauryl Sulfate Abrogates Human Immunodeficiency Virus Infectivity by Affecting Viral AttachmentAntimicrobial Agents and Chemotherapy, 2001
- Repertoire of Chemokine Receptor Expression in the Female Genital Tract: Implications for Human Immunodeficiency Virus TransmissionThe American Journal of Pathology, 1998
- Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4The Journal of Experimental Medicine, 1997